Additional definitive proxy soliciting materials and Rule 14(a)(12)[...]
REGENXBIO Announces Lancet Publication of Phase I/IIa Study Evaluating[...]
04/07/2021 | Press release | Distributed by Public on 04/07/2021 17:14
Please select the service you want to use:
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact